BioAge Labs Inc.

NASDAQ: BIOA · Real-Time Price · USD
4.47
-0.09 (-1.97%)
At close: Aug 14, 2025, 3:59 PM
4.46
-0.22%
After-hours: Aug 14, 2025, 04:20 PM EDT

BioAge Labs Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-78.19M -48.4M -39.97M
Interest Income
n/a 2.43M 465K
Pretax Income
-71.11M -63.85M -39.72M
Net Income
-71.11M -63.85M -39.72M
Selling & General & Admin
19.16M 14.51M 9.45M
Research & Development
59.04M 33.89M 30.52M
Other Expenses
n/a n/a n/a
Operating Expenses
78.19M 48.4M 39.97M
Interest Expense
n/a 7.79M 241K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 48.4M 39.97M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
10.73M 7.47M 7.46M
Shares Outstanding (Diluted)
10.73M 7.47M 7.46M
EPS (Basic)
-6.63 -8.55 -5.32
EPS (Diluted)
-6.63 -8.55 -5.32
EBITDA
-78.19M -55.9M -39.35M
EBIT
-68.74M -56.06M -39.48M
Depreciation & Amortization
-4.72M 162K 129K